Whilst considerable research has described the biological basis underpinning the clinical heterogeneity observed in M-CLL and U-CLL, it remains unclear to what extent these differing biological features reflect the tumour cells innate pre/post-germinal centre origin or their acquired BCR signalling competence. Here, BCR is linked to neoplasm.